Kimberly Chong

Array ( [id] => 7328161 [patent_doc_number] => 20040253604 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-16 [patent_title] => 'RNA-mediated gene modulation' [patent_app_type] => new [patent_app_number] => 10/663875 [patent_app_country] => US [patent_app_date] => 2003-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 12147 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0253/20040253604.pdf [firstpage_image] =>[orig_patent_app_number] => 10663875 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7328740 [patent_doc_number] => 20040253728 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-16 [patent_title] => 'New method' [patent_app_type] => new [patent_app_number] => 10/416456 [patent_app_country] => US [patent_app_date] => 2003-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 24444 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0253/20040253728.pdf [firstpage_image] =>[orig_patent_app_number] => 10416456 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7127275 [patent_doc_number] => 20050059019 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-17 [patent_title] => 'Gene-related RNAi transfection method' [patent_app_type] => utility [patent_app_number] => 10/661005 [patent_app_country] => US [patent_app_date] => 2003-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4949 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20050059019.pdf [firstpage_image] =>[orig_patent_app_number] => 10661005 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5986544 [patent_doc_number] => 20110098200 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-28 [patent_title] => 'Methods using dsdna to mediate rna interference (rnai)' [patent_app_type] => utility [patent_app_number] => 10/526475 [patent_app_country] => US [patent_app_date] => 2003-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 15871 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0098/20110098200.pdf [firstpage_image] =>[orig_patent_app_number] => 10526475 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7104000 [patent_doc_number] => 20050106726 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-19 [patent_title] => 'RNA interference mediated inhibition of platelet-derived endothelial cell growth factor (ECGF1) gene expression using short interfering nucleic acid (siNA)' [patent_app_type] => utility [patent_app_number] => 10/652791 [patent_app_country] => US [patent_app_date] => 2003-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 53204 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0106/20050106726.pdf [firstpage_image] =>[orig_patent_app_number] => 10652791 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7470862 [patent_doc_number] => 20040096882 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-20 [patent_title] => 'RNAi probes targeting cancer-related proteins' [patent_app_type] => new [patent_app_number] => 10/646436 [patent_app_country] => US [patent_app_date] => 2003-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 7746 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0096/20040096882.pdf [firstpage_image] =>[orig_patent_app_number] => 10646436 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 581942 [patent_doc_number] => 07452987 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-11-18 [patent_title] => 'Interfering RNA molecules' [patent_app_type] => utility [patent_app_number] => 10/633630 [patent_app_country] => US [patent_app_date] => 2003-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 46 [patent_no_of_words] => 18863 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 163 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/452/07452987.pdf [firstpage_image] =>[orig_patent_app_number] => 10633630 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7281278 [patent_doc_number] => 20040063655 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-01 [patent_title] => 'Antisense modulation of transforming growth factor-beta expression' [patent_app_type] => new [patent_app_number] => 10/633163 [patent_app_country] => US [patent_app_date] => 2003-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 20000 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20040063655.pdf [firstpage_image] =>[orig_patent_app_number] => 10633163 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7289397 [patent_doc_number] => 20040110235 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-10 [patent_title] => 'Regulated aptamer therapeutics' [patent_app_type] => new [patent_app_number] => 10/627543 [patent_app_country] => US [patent_app_date] => 2003-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 13870 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20040110235.pdf [firstpage_image] =>[orig_patent_app_number] => 10627543 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7338169 [patent_doc_number] => 20040132984 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-08 [patent_title] => 'Antisense compounds, methods and compositions for treating NGAL-related inflammatory disorders' [patent_app_type] => new [patent_app_number] => 10/620576 [patent_app_country] => US [patent_app_date] => 2003-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9198 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0132/20040132984.pdf [firstpage_image] =>[orig_patent_app_number] => 10620576 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7206799 [patent_doc_number] => 20040087533 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-06 [patent_title] => 'Antisense compounds, methods and compositions for treating MMP-12 related inflammatory disorders' [patent_app_type] => new [patent_app_number] => 10/619906 [patent_app_country] => US [patent_app_date] => 2003-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9446 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20040087533.pdf [firstpage_image] =>[orig_patent_app_number] => 10619906 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7314276 [patent_doc_number] => 20040033979 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-19 [patent_title] => 'Antisense modulation of Fas mediated signaling' [patent_app_type] => new [patent_app_number] => 10/619220 [patent_app_country] => US [patent_app_date] => 2003-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22631 [patent_no_of_claims] => 126 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0033/20040033979.pdf [firstpage_image] =>[orig_patent_app_number] => 10619220 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7341324 [patent_doc_number] => 20040191220 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-30 [patent_title] => 'WWP1 and uses thereof' [patent_app_type] => new [patent_app_number] => 10/618408 [patent_app_country] => US [patent_app_date] => 2003-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 15072 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20040191220.pdf [firstpage_image] =>[orig_patent_app_number] => 10618408 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6905512 [patent_doc_number] => 20050100907 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-12 [patent_title] => 'Method and medicament for inhibiting the expression of a given gene' [patent_app_type] => utility [patent_app_number] => 10/612179 [patent_app_country] => US [patent_app_date] => 2003-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6039 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0100/20050100907.pdf [firstpage_image] =>[orig_patent_app_number] => 10612179 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4688761 [patent_doc_number] => 20080032942 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-07 [patent_title] => 'RNA interference mediated treatment of Alzheimer\'s disease using short interfering nucleic acid (siNA)' [patent_app_type] => utility [patent_app_number] => 10/607933 [patent_app_country] => US [patent_app_date] => 2003-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 52856 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20080032942.pdf [firstpage_image] =>[orig_patent_app_number] => 10607933 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5872875 [patent_doc_number] => 20060165665 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-27 [patent_title] => 'Immunomodulation using altered dendritic cells' [patent_app_type] => utility [patent_app_number] => 10/517275 [patent_app_country] => US [patent_app_date] => 2003-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 10449 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20060165665.pdf [firstpage_image] =>[orig_patent_app_number] => 10517275 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7403644 [patent_doc_number] => 20040023908 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-05 [patent_title] => 'Antisense modulation of a20 expression' [patent_app_type] => new [patent_app_number] => 10/363198 [patent_app_country] => US [patent_app_date] => 2003-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25055 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0023/20040023908.pdf [firstpage_image] =>[orig_patent_app_number] => 10363198 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7267212 [patent_doc_number] => 20040244062 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-02 [patent_title] => 'Use of protein inhibitors as antithrombotic agents' [patent_app_type] => new [patent_app_number] => 10/453314 [patent_app_country] => US [patent_app_date] => 2003-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8788 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0244/20040244062.pdf [firstpage_image] =>[orig_patent_app_number] => 10453314 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5585967 [patent_doc_number] => 20090105169 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-23 [patent_title] => 'ALLELE-SPECIFIC SILENCING OF DISEASE GENES' [patent_app_type] => utility [patent_app_number] => 10/522954 [patent_app_country] => US [patent_app_date] => 2003-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 32653 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20090105169.pdf [firstpage_image] =>[orig_patent_app_number] => 10522954 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6678550 [patent_doc_number] => 20030228691 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-11 [patent_title] => 'Processes for inhibiting gene expression using polynucleotides' [patent_app_type] => new [patent_app_number] => 10/440983 [patent_app_country] => US [patent_app_date] => 2003-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8461 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0228/20030228691.pdf [firstpage_image] =>[orig_patent_app_number] => 10440983 [rel_patent_id] =>[rel_patent_doc_number] =>)